Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.  [electronic resource] 

 -  The New England journal of medicine  10 2018 
 - 1403-1415 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1800474  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--pharmacology<br/>Drug Resistance, Bacterial--genetics<br/>Ethambutol--pharmacology<br/>Genome, Bacterial<br/>Genotype<br/>Humans<br/>Isoniazid--pharmacology<br/>Microbial Sensitivity Tests<br/>Mutation<br/>Mycobacterium tuberculosis--drug effects<br/>Phenotype<br/>Pyrazinamide--pharmacology<br/>Rifampin--pharmacology<br/>Tuberculosis--drug therapy<br/>Whole Genome Sequencing